Evidence map›Paper›PMID 32935556›Full record

ArticleAIDS research and human retroviruses2021

Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana.

Catherine K Koofhethile, Sikhulile Moyo, Kenanao P Kotokwe, Charlotte Chang, Patrick Mokgethi, Lorato Muchoba, Selebogo Mokgweetsi, Joseph Makhema, Shahin Lockman, Simani Gaseitsiwe and 5 more

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Catherine K KoofhethileBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Sikhulile MoyoBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Kenanao P KotokweBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Charlotte ChangHarvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Patrick MokgethiBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Lorato MuchobaBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Selebogo MokgweetsiBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Joseph MakhemaBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Shahin LockmanBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Simani GaseitsiweBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Tulio de OliveiraCollege of Health Sciences, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal (UKZN), Durban, South Africa.
M EssexBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Roger ShapiroBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Phyllis KankiHarvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Vladimir NovitskyBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Botswana Harvard AIDS Institute Partnership · BWHarvard University · USUniversity of KwaZulu-Natal · ZA

Funding

Training in HIV Genomics, Treatment, and Cure Research in BotswanaD43TW009610 · FIC · THE BOTSWANA HARVARD HEALTH PARTNERSHIP · PI SHAHIN LOCKMAN, Joseph Moeketsi Makhema · 2013 to 2026
$4.4M
Expansion of research and mentoring to improve birth outcomes and treatment outcomes among HIV-affected children in BotswanaK24AI131924 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Roger L Shapiro · 2018 to 2026
$1.6M
FIC NIH HHS D43 TW009610NIAID NIH HHS K24 AI131924
6 · The paper itself

Abstract

Although antiretroviral therapy (ART) effectively suppresses HIV replication, the latent reservoir remains the barrier to HIV eradication. It remains unknown whether long-term ART impacts levels of inducible replication-competent provirus. To address this knowledge gap, we assessed the proviral reservoir in HIV-1 perinatally infected adolescents having received ART for >13 years. We recruited 15 vertically infected adolescents living with HIV in Botswana. Historical viral load, CD4

Indexed as

HIV-1HIV InfectionsAdolescentBotswanaCD4-Positive T-LymphocytesHumansLeukocytes, MononuclearProvirusesViral Loadadolescentantiretroviral therapyHIVinducible replication competentreservoirviral suppression

Identifiers

PMID32935556
PMCPMC7864094
OpenAlexW3087319827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.